| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |